Samsung Biologics Co Ltd banner

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 1 422 000 KRW 42.2%
Market Cap: ₩65.8T

Intrinsic Value

The intrinsic value for Samsung Biologics Co Ltd (207940) under the Base Case is 933 195.13 KRW. Compared with the current market price of 1 422 000 KRW, the stock appears Overvalued by 34% .

Intrinsic Value
933 195.13 KRW
Overvaluation 34%
Intrinsic Value
Price ₩1 422 000
Bear Case
Base Case
Bull Case
Monitor Samsung Biologics Co Ltd
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ₩746 556.1
Get notified when the price drops into your buy zone
Current Price ₩1 422 000
Intrinsic Value ₩933 195.13
Margin of Safety 20% ₩746 556.1
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about Samsung Biologics Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Samsung Biologics Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Samsung Biologics Co Ltd.

Explain Valuation
Alternatives to Samsung Biologics Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Samsung Biologics Co Ltd stock?

The intrinsic value for Samsung Biologics Co Ltd (207940) under the Base Case is 933 195.13 KRW.

Is Samsung Biologics Co Ltd stock undervalued or overvalued?

Compared with the current market price of 1 422 000 KRW, the stock appears Overvalued by 34% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett